Clinical Trial Update: Prolonged Tamoxifen Compared With Shorter Tamoxifen in Treating Patients Who Have Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing prolonged (extended-duration) tamoxifen therapy with shorter duration in patients with breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Tamoxifen (tamoxifen)

Snippet

Sponsor: University of Oxford | Conditions: Breast Cancer | Phase 3 | Status: UNKNOWN